U.S. Entertainment Stock News

Annual earnings and new shelf registration reshape Relay Therapeutics story Relay Therapeutics (RLAY) has just reported its full year 2025 results, pairing higher reported revenue and a smaller net loss with a new US$96.2 million shelf registration for potential common stock issuance. See our latest analysis for Relay Therapeutics. The earnings update, new US$96.2 million shelf registration and recent conference appearance come as Relay Therapeutics’ share price trades at US$9.89, with a 90...

Why Apogee Therapeutics is in focus after earnings and a new shelf registration Apogee Therapeutics (APGE) has come into focus after reporting a full year 2025 net loss of US$255.84 million, along with a new US$287.29 million shelf registration for additional common stock. See our latest analysis for Apogee Therapeutics. At a share price of US$73.05, Apogee Therapeutics has delivered a 30 day share price return of 17.37% and a 1 year total shareholder return of 94.59%. This suggests that...

In early March 2026, Radware launched a cloud-based Web DDoS Protection service for encrypted traffic that blocks sophisticated layer 7 attacks without requiring SSL certificate sharing or traffic decryption, addressing privacy, regulatory, and key management concerns. The company claims to be the only provider offering this kind of cloud-based encrypted DDoS protection, combining AI-driven behavioral analysis with flexible cloud, on-premises, hybrid, and Kubernetes-native deployment...

Mason Capital Management recently disclosed in an SEC filing that it purchased more than 1.1 million additional shares of Brookdale Senior Living, materially increasing its ownership position and signaling stronger institutional interest in the senior living operator. This larger stake, built as Brookdale continues to emphasize operational efficiency and demographic demand tailwinds, raises fresh questions about how institutional involvement could shape the company’s longer-term direction...

Investor worries around hidden risks in the private credit market have weighed on regional banks, and Byline Bancorp (BY) has been pulled into that broader sector pressure as sentiment has cooled. See our latest analysis for Byline Bancorp. The share price has softened recently, with a 1-day share price return of 1.72% and a 30-day share price return of 8.03%, even though the 1-year total shareholder return of 19.24% and 3-year total shareholder return of 63.58% point to momentum that has...

In late February 2026, Privia Health Group reported fourth-quarter 2025 revenue of US$541.17 million and net income of US$9.15 million, alongside full-year 2025 revenue of US$2.12 billion and net income of US$22.92 million, while separately publishing a case study on a nationwide colorectal cancer screening program that reached over 100,000 patients. The colorectal cancer initiative, integrating Amalgam Rx’s clinical workflows and Exact Sciences’ Cologuard test into Privia’s EHR, lifted...

Morningstar’s new AI assistant and what it could mean for the stock Morningstar (MORN) has rolled out a new AI assistant in beta to part of its 4,000 advisor base, integrating research, portfolio analysis, and proposal tools through natural language prompts within its Direct Advisory Suite. See our latest analysis for Morningstar. The new AI assistant arrives alongside other recent initiatives, such as Morningstar’s collaboration with the University of Illinois and fresh PitchBook research on...

Why Chesapeake Utilities is on investors’ radar Chesapeake Utilities (CPK) has been drawing attention after recent share price moves, with the stock roughly flat over the past day but slightly weaker over the past week and higher over the past 3 months. See our latest analysis for Chesapeake Utilities. Looking beyond the latest move, Chesapeake Utilities’ 30 day share price return of 1.83% and 90 day share price return of 5.19% sit alongside a 1 year total shareholder return of 4.86%,...

In late February 2026, Solventum Corporation reported fourth-quarter 2025 revenue of US$1,998 million and net income of US$63 million, alongside full-year 2025 revenue of US$8.33 billion and net income of US$1.56 billion, while also announcing a US$1 billion share repurchase authorization and openness to tuck-in acquisitions. Management highlighted portfolio optimization and capital returns as key priorities, signaling an emphasis on using the company’s healthier balance sheet and cash...

In March 2026, DaVita Inc. presented at the TD Cowen 46th Annual Health Care Conference in Boston, where CFO Joel Ackerman and Investor Relations head Nic Eliason outlined the company’s current performance, structural challenges in its dialysis business, and ongoing clinical and investment initiatives. Management highlighted that while dialysis patient volumes fell during 2025, DaVita is leaning on clinical programs and integrated care investments to counter these pressures, even as much of...

Recently, Plains All American Pipeline raised its annualized distribution 10% to US$1.67 per unit and outlined 2026 EBITDA guidance between US$2.68 billion and US$2.83 billion, supported by capital expenditure reductions and fee-based, long-term contracts that reduce sensitivity to oil price swings. This combination of a higher payout, cost discipline, and predominantly volume-driven revenue has reinforced perceptions of resilient cash flow and strengthened analyst confidence in the...

What the latest move in Minimed Group (MMED) could mean for investors Minimed Group (MMED) shares slipped about 7.6% in the latest session, catching investors’ attention as they weigh a medical technology business with US$2,886.0 in revenue against a net loss of US$211.0. See our latest analysis for Minimed Group. That 7.6% one day share price return decline, with the share price now at US$18.49 and year to date share price return also down 7.6%, suggests recent sentiment has cooled rather...

Why the expanded buyback matters for Bread Financial Holdings (BFH) Bread Financial Holdings (BFH) has moved into focus after its board expanded the company’s share repurchase authorization, adding US$600 million and taking total approved buybacks to US$1.0b with no set end date. This larger buyback pool sits alongside an analyst rating upgrade and recent institutional selling. Together, these developments provide several different signals to consider when evaluating the stock’s risk and...

Tri Pointe Homes, Inc. recently reported fourth-quarter 2025 revenue of US$954.59 million and net income of US$60.16 million, with full-year revenue of US$3.40 billion and net income of US$241.09 million, all lower than the prior year. A day later, the company highlighted product expansion by unveiling Aspire at Holladay Hills in Utah, its first townhome community in the state, featuring 57 units with interiors designed by Emmy-winning Bobby Berk. We’ll now examine how the weaker 2025...

Recently, Liquidity Services was highlighted by Zacks as one of four services-sector stocks benefiting from favorable earnings estimate revisions and a strong buy rating, underscoring its role as an e-commerce marketplace for surplus assets. This recognition reflects growing analyst confidence in the company’s business model and earnings profile, rather than any single operational announcement. Next, we’ll consider how this uptick in analyst optimism and earnings estimate revisions could...

In late February and early March 2026, Ionis Pharmaceuticals reported 2025 results, received FDA Priority Review for olezarsen in severe hypertriglyceridemia, and presented new Phase 3 data for its approved hereditary angioedema therapy DAWNZERA at the AAAAI 2026 meeting in Philadelphia. Together, the Priority Review for olezarsen and expanded DAWNZERA data highlight Ionis’s push to turn its RNA platform into multiple commercialized cardiovascular and immunology therapies. We’ll now examine...

Earlier this month, Tango Therapeutics reported full-year 2025 results showing revenue of US$62.38 million and a net loss of US$101.59 million, alongside a new clinical trial collaboration in which Erasca will supply its pan-RAS agent ERAS-0015 for combination studies with vopimetostat in MTAP-deleted pancreatic and RAS-mutant lung cancers. The Erasca partnership pairs a pan-RAS molecular glue with Tango’s selective PRMT5 inhibitor, aiming to exploit MTAP deletion biology for a dual-targeted...

Adobe and Major League Baseball have expanded their multi year partnership, with Adobe becoming the official Presenting Sponsor of MLB Opening Day through 2028. Adobe will supply AI powered marketing and content tools aimed at creating more personalized, real time engagement for MLB fans. The agreement broadens Adobe's presence in sports and entertainment, tying its generative AI directly to a major US sports property. For investors watching Adobe, ticker NasdaqGS:ADBE, this deal adds a...

Navios Maritime Partners L.P. recently presented at the DNB Carnegie Energy & Shipping Conference in Oslo, where its CFO and COO outlined current industry conditions and company positioning. Alongside this, CEO Angeliki Frangou has argued that rising geopolitical tensions, especially around Iran and the Strait of Hormuz, are reshaping global trade patterns and driving higher crude shipping rates under an emerging mercantilist, security-first world order. We will now examine how management’s...

Why Somnigroup International (SGI) is on investors’ radar Somnigroup International (SGI) recently rebranded from Tempur Sealy International, a change that draws attention to how this bedding manufacturer’s shares have behaved after a 3% one day and 8% week decline. See our latest analysis for Somnigroup International. The recent 1 day share price return of 3.05% and 7 day return of 8.49% sit against a 30 day share price decline of 16.94% and a year to date decline of 9.85%, while the 1 year...

In early March 2026, Western Alliance Bancorporation disclosed it had written off a US$126.4 million commercial loan and filed a lawsuit alleging breach of contract and fraud against Jefferies Financial Group and affiliates after they stopped making payments under a forbearance agreement tied to bankrupt auto supplier First Brands Group. The bank said it would seek to lessen the impact of this charge-off through gains on securities sales and expense reductions while pursuing full recovery of...

CMS Energy (NYSE:CMS) reported strong Q4 2025 results and raised its 2026 EPS guidance. The company introduced a 20-year plan centered on expanding solar and wind capacity. Management highlighted the long-term shift towards renewable energy alongside financial updates. For investors watching NYSE:CMS, these updates come with the stock at $77.16 and a return of 53.7% over the past 5 years. The recent 9.6% gain year to date and 42.6% return over 3 years show how the share price has moved over...

California Resources Corporation recently released its fourth-quarter and full-year 2025 results, updated its 2026 production and earnings guidance, confirmed a US$0.405 quarterly dividend, and completed a US$1.18 billion buyback covering 27,014,408 shares, representing 33.93% of its share count. The combination of higher 2025 revenue, reduced net income, detailed 2026 net income guidance of US$50 million to US$80 million, and extensive capital returns through buybacks and dividends gives...

In February 2026, CBIZ, Inc. reported its fourth-quarter and full-year 2025 results, with sales rising to US$542.66 million for the quarter and US$2.76 billion for the year, alongside improved profitability and a recently completed share repurchase of 2,504,000 shares for US$168.30 million. CBIZ also issued 2026 revenue guidance of US$2.80 billion to US$2.90 billion, which, together with the buyback completion, highlights management’s confidence in the company’s financial position and future...